secwatch.observer — SEC 8-K summary
======================================

Issuer:     NORDSON CORP (NDSN)
CIK:        0000072331
Form:       8-K
Filed at:   2023-08-21T23:59:59+00:00
Accession:  0000072331-23-000141
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nordson Q3 sales down 2% to $649M; adjusted EPS $2.35; FY23 guidance narrowed
-----------------------------------------------------------------------------

- Sales $649M (-2% YoY); organic sales -5% offset by acquisitions; GAAP EPS $2.22, adjusted EPS $2.35.
- EBITDA $208M (32% of sales); adjusted operating profit $181M (28% of sales).
- Electronics & biopharma weakness; medical interventional solutions and polymer processing posted growth.
- FY23 guidance narrowed: revenue growth 0-2% over record FY22, adjusted EPS $8.90-$9.05.
- ARAG acquisition expected to close late August, contributing ~$20-30M sales in Q4.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/72331/000007233123000141/0000072331-23-000141-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/72331/000007233123000141/ndsn-20230821.htm
  HTML page:      https://secwatch.observer/filing/0000072331-23-000141

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer